Clinical Trial Update: A Trial to Learn How Well Linvoseltamab Works Compared to the Combination of Elotuzumab, Pomalidomide and Dexamethasone for Adult Participants With Relapsed/Refractory Multiple Myeloma [Phase 3]

View source ↗

Summary

Phase 3 clinical trial comparing Linvoseltamab to the combination of Elotuzumab, Pomalidomide, and Dexamethasone in adults with relapsed/refractory multiple mye…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• DEXAMETHASONE (Dexamethasone)
• Elotuzumab (elotuzumab)
• Linvoseltamab
• Pomalidomide (Pomalidomide)

Snippet

Sponsor: Regeneron Pharmaceuticals | Conditions: Relapsed Refractory Multiple Myeloma (RRMM) | Phase 3 | Status: RECRUITING